{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:40:59Z","timestamp":1678560059394},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:00:00Z","timestamp":1182211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:00:00Z","timestamp":1182211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10637-007-9067-2","type":"journal-article","created":{"date-parts":[[2007,6,18]],"date-time":"2007-06-18T20:26:06Z","timestamp":1182198366000},"page":"559-564","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer"],"prefix":"10.1007","volume":"25","author":[{"given":"Elisabetta","family":"Campagnoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"De Vincenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Luca","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Romano","family":"Lutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Alloisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector Jos\u00e8","family":"Soto Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Cavina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,19]]},"reference":[{"key":"9067_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH (2002) For the eastern cooperative oncology group: comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346:92\u201398","journal-title":"N Engl J Med"},{"key":"9067_CR2","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","volume":"19","author":"K Kelly","year":"2001","unstructured":"Kelly K, Crowley J, Bunn Jr PA, Presant CA, Grevstad PK, Moinpour CM, Ramsey SD, Wozniak AJ, Weiss GR, Moore DF, Israel VK, Livingston RB, Gandara DR (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer. A South West Oncology Group trial. J Clin Oncol 19:3210\u20133218","journal-title":"J Clin Oncol"},{"issue":"21","key":"9067_CR3","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","volume":"20","author":"GV Scagliotti","year":"2002","unstructured":"Scagliotti GV, De Marinis F, Rinaldi M, Crin\u00f2 L, Gridelli C, Ricci S, Matano E, Boni C, Marangolo M, Failla G, Altavilla G, Adamo V, Ceribelli A, Clerici M, Di Costanzo F, Frontini L, Tonato M (2002) For the Italian Lung Cancer Project: Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. J Clin Oncol 20(21):4285\u20134291","journal-title":"J Clin Oncol"},{"key":"9067_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.annonc.a058687","volume":"5","author":"A Depierre","year":"1994","unstructured":"Depierre A, Chastang CI, Quoix E, Lebeau B, Blanchon F, Paillot N, Lemarie E, Milleron B, Moro D, Clavier J, Herman D, Tuchais E, Jacoulet P, Brechot JM, Cordier JF, Solal-Celigny P, Badri N, Besenval M (1994) Vinorelbine versus vinorelbine plus cisplatin in advanced NSCLC: a randomized trial. Ann Oncol 5:37\u201342","journal-title":"Ann Oncol"},{"issue":"2","key":"9067_CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","volume":"12","author":"T Le Chevalier","year":"1994","unstructured":"Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S et al. (1994) Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin and vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 12(2):360\u2013367","journal-title":"J Clin Oncol"},{"key":"9067_CR6","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao M-S, Gandara D, Kesler K, Demmy T, Shepherd F (2005) For the National Cancer Institute of Canada Clinical Trials Group and the National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators: Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 352:2589\u20132597","journal-title":"N Engl J Med"},{"key":"9067_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa031644","volume":"350","author":"The International Adjuvant Lung Cancer Trial Collaborative Group","year":"2004","unstructured":"The International Adjuvant Lung Cancer Trial Collaborative Group (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351\u2013360","journal-title":"N Engl J Med"},{"key":"9067_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"J Douillard","year":"2006","unstructured":"Douillard J, Rosell R, Delena M, Carpagnano F, Ramlau R, Gonzales-Larriba JL, Grodzki T, Pereira JR, Le Groumellec A, Lorusso V, Clary C, Torres AJ, Dahabreh J, Souquet P-J, Astudillo J, Fournel P, Artal-Cortes A, Jassem J, Koubkova L, His P, Riggi M, Hurteloup P (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7:719\u2013727","journal-title":"Lancet Oncol"},{"issue":"Suppl 2","key":"9067_CR9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0169-5002(05)80224-7","volume":"49","author":"V Gebbia","year":"2005","unstructured":"Gebbia V, Galetta D, Caruso M (2005) Weekly vinorelbine plus cisplatin versus day 1+8 vinorelbine with cisplatin in advanced non-small cell lung cancer: end results of a phase III trial. Lung Cancer 49(Suppl 2):S32","journal-title":"Lung Cancer"},{"key":"9067_CR10","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1023\/A:1013180903805","volume":"12","author":"M Marty","year":"2001","unstructured":"Marty M, Fumoleau P, Adenis A, Rousseau Y, Merrouche Y, Robinet G, Senac I, Puozzo C (2001) Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors. Ann Oncol 12:1643\u20131649","journal-title":"Ann Oncol"},{"key":"9067_CR11","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/annonc\/mdg455","volume":"14","author":"J Jassem","year":"2003","unstructured":"Jassem J, Kosmidis P, Ramlau R, Zarogoulidis K, Novakova L, Breton J, Etienne P-L, Seebacher C, Grivaux M, Ojala A, Aubert D, Lefresne F (2003) Oral vinorelbine in combination with cisplatin: a novel active regimen in advance non-small cell lung cancer. Ann Oncol 14:1634\u20131639","journal-title":"Ann Oncol"},{"key":"9067_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.lungcan.2004.10.006","volume":"48","author":"M De Lena","year":"2005","unstructured":"De Lena M, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J (2005) Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lung Cancer 48:129\u2013135","journal-title":"Lung Cancer"},{"issue":"1","key":"9067_CR13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","volume":"15","author":"G Liu","year":"1997","unstructured":"Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15(1):110\u2013115","journal-title":"J Clin Oncol"},{"issue":"8","key":"9067_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1023\/A:1008389106575","volume":"10","author":"F Nol\u00e8","year":"1999","unstructured":"Nol\u00e8 F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U (1999) Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN). Ann Oncol 10(8):993\u2013996","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"9067_CR15","first-page":"S269","volume":"27","author":"M Magagnoli","year":"2001","unstructured":"Magagnoli M, Balzarotti M, Sarina B, Castagna L, Timofeeva I, Nozza A, Bertuzzi A, Siracusano L, Santoro A (2001) Mobilizing potential of IGEV (ifosfamide, gemcitabine, vinorelbine) chemotherapy in refractory\/relapsed Hodgkin\u2019s disease (HD). Bone Marrow Transplant 27(Suppl 1):S269","journal-title":"Bone Marrow Transplant"},{"key":"9067_CR16","first-page":"2846","volume":"22","author":"PA Zucali","year":"2003","unstructured":"Zucali PA, Soto Parra HJ, Cavina R, Campagnoli E, Latteri F, Ginanni V, Biancofiore G, Ferrari B, Morenghi E, Santoro A (2003) Results of a dose-findings study with a short-schedule cisplatin (P) and Vinorelbine (V) in non-small cell lung cancer (NSCLC): an attempt to improve feasibility and compliance. Proc Am Soc Clin Oncol 22:2846a","journal-title":"Proc Am Soc Clin Oncol"},{"key":"9067_CR17","volume-title":"Common toxicity criteria, version 3.0","author":"National Cancer Institute","year":"2003","unstructured":"National Cancer Institute (2003) Common toxicity criteria, version 3.0. National Cancer Institute, Bethesda, MD"},{"key":"9067_CR18","volume-title":"Cancer staging manual","author":"AJCC","year":"2002","unstructured":"AJCC (2002) Cancer staging manual, 6th edn. Springer, New York (March)","edition":"6"},{"key":"9067_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2307\/2530297","volume":"38","author":"TR Fleming","year":"1982","unstructured":"Fleming TR (1982) One-sample multiple testing procedures for phase II clinical trials. Biometrics 38:143\u2013151","journal-title":"Biometrics"},{"key":"9067_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1200\/JCO.2004.08.134","volume":"22","author":"American Society of Clinical Oncology","year":"2004","unstructured":"American Society of Clinical Oncology (2004) Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer. J Clin Oncol 22:330\u2013353","journal-title":"J Clin Oncol"},{"key":"9067_CR21","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/annonc\/mdf316","volume":"13","author":"PJ Souquet","year":"2002","unstructured":"Souquet PJ, Tan EH, Rodriguez Pereira J, Van Klaveren R, Price A, Gatzemeier U, Jaworski M, Burillon JP, Aubert D (2002) GLOB1: a phase III trial comparing the combination of vinorelbine and cisplatin (NP) versus vinorelbine, ifosfamide and cisplatin (NIP) in metastatic non-small cell lung cancer patients (NSCLC). Ann Oncol 13:1853\u20131861","journal-title":"Ann Oncol"},{"key":"9067_CR22","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1200\/JCO.1998.16.7.2459","volume":"16","author":"AJ Wozniak","year":"1998","unstructured":"Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Spiridonidis CH, Baker LH, Albain KS, Kelly K, Taylor SA, Gandara DR, Livingston RB (1998) Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer. J Clin Oncol 16:2459\u20132465","journal-title":"J Clin Oncol"},{"key":"9067_CR23","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1200\/JCO.2003.12.046","volume":"21","author":"F Fossella","year":"2003","unstructured":"Fossella F, Pereira JR, von Pawel J Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP (2003) Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group. J Clin Oncol 21:3016\u20133024","journal-title":"J Clin Oncol"},{"key":"9067_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/14740338.4.5.915","volume":"4","author":"V Gebbia","year":"2005","unstructured":"Gebbia V, Puozzo C (2005) Oral versus intravenous vinorelbine: clinical safety profile. Expert Opin Drug Saf 4:1\u201314","journal-title":"Expert Opin Drug Saf"},{"key":"9067_CR25","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1023\/A:1012539225493","volume":"12","author":"J Jassem","year":"2001","unstructured":"Jassem J, Ramlau R, Karnicka-Mlodkowska H, Krawczyk K, Krzakowski M, Zatloukal P, Lemarie E, Hartmann W, Novakova L, O\u2019Brien M, Depierre A (2001) A multicenter randomized phase II study of oral versus intravenous vinorelbine in advanced non-small cell lung cancer patients. Ann Oncol 12:1375\u20131381","journal-title":"Ann Oncol"},{"key":"9067_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/annonc\/mdh233","volume":"15","author":"MER O\u2019Brien","year":"2004","unstructured":"O\u2019Brien MER, Szczesna A, Karnicka H, Zatloukal P, Eisen T, Hartman W, Kasan P, Longerey B, Lefresne F (2004) Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II study. Ann Oncol 15:921\u2013927","journal-title":"Ann Oncol"},{"key":"9067_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2006.11.017","volume":"56","author":"Y-M Chen","year":"2007","unstructured":"Chen Y-M, Yu C-J, Yang C-H, Perng R-P, Tsai C-M, Shih J-F, Cheng A-L, Lefresne F, Barbier M, Pouget J-C, Yang P-C (2007) A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung cancer. Lung Cancer 56:89\u201395","journal-title":"Lung Cancer"},{"key":"9067_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.lungcan.2003.09.002","volume":"43","author":"SA Laurie","year":"2004","unstructured":"Laurie SA, Logan D, Markman BR, Mackay JA, Evans WK, Lung Cancer Disease Site Group of Cancer Care Ontario\u2019s Program in Evidence-based Care (2004) Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. Lung Cancer 43:223\u2013240","journal-title":"Lung Cancer"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-007-9067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-007-9067-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-007-9067-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-007-9067-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:26:16Z","timestamp":1678559176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-007-9067-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,19]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["9067"],"URL":"https:\/\/doi.org\/10.1007\/s10637-007-9067-2","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,19]]},"assertion":[{"value":"16 April 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}